|
2 Companies |
|
2 Products |
|
2 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
1 News |
|
- RG4733 / Roche
Trial termination: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (clinicaltrials.gov) - Apr 30, 2013
P1/2, N=129, Terminated, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Terminated